Home > > > > > Report Detail

Global Insulin Glargine Market Insights, Forecast to 2026

Publisher Name :
Date: 05-May-2020
No. of pages: 113
Inquire Before Buying

Insulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert).

Insulin glargine is a long-acting, man-made version of human insulin. Insulin glargine works by replacing the insulin that is normally produced by the body and by helping move sugar from the blood into other body tissues where it is Used for energy. It also stops the liver from producing more sugar.

There are two type of Insulin glargine, which are Single Dose Vial and Pre-filled Syringe in the market. Considering its function, Insulin glargine is Used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also Used to treat people with type 2 diabetes (condition in which the body does not Used insulin normally and, therefore, cannot control the amount of sugar in the blood) who need insulin to control their diabetes.

We can see that there are just a few companies produce Insulin glargine, the production of them almost approach to 70% of whole market. They have seted plant in Japan, China, German, India, North Americato produce Insulin glargine, and China is the largest plant for Insulin glargine in the world and also the largest consumption country. As the amount of diabetes of increasing of China, the Chinese market will be bigger than North America.

The Industry is affected by the economic development level and policy, so it's important to put an eye to economic indexes and leaders' prefer. With the global economic recovery, more and more people pay attention to care about personal health, especially in underdevelopment regions that have a large population and fast economic growth, the need of Insulin glargine will increase.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Insulin Glargine 3900 market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the Insulin Glargine 3900 industry.

Based on our recent survey, we have several different scenarios about the Insulin Glargine 3900 YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 6174.3 million in 2019. The market size of Insulin Glargine 3900 will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Insulin Glargine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Insulin Glargine market in terms of both revenue and volume.

Players, stakeholders, and other participants in the global Insulin Glargine market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.

Sales and Pricing Analyses

Readers are provided with deeper sales analysis and pricing analysis for the global Insulin Glargine market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.

In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.

Regional and Country-level Analysis

The report offers an exhaustive geographical analysis of the global Insulin Glargine market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.

Competition Analysis

In the competitive analysis section of the report, leading as well as prominent players of the global Insulin Glargine market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Insulin Glargine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Insulin Glargine market.

The following manufacturers are covered in this report:

- Sanofi-Aventis

- Ganlee

- Biocon

Insulin Glargine Breakdown Data by Type

- Single Dose Vial

- Pre-filled Syringe

Insulin Glargine Breakdown Data by Application

- Treat type2 diabetes

- Treat type1 diabetes

Global Insulin Glargine Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Insulin Glargine Product Introduction
1.2 Market Segments
1.3 Key Insulin Glargine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Insulin Glargine Market Size Growth Rate by Type
1.4.2 Single Dose Vial
1.4.3 Pre-filled Syringe
1.5 Market by Application
1.5.1 Global Insulin Glargine Market Size Growth Rate by Application
1.5.2 Treat type2 diabetes
1.5.3 Treat type1 diabetes
1.6 Coronavirus Disease 2019 (Covid-19): Insulin Glargine Industry Impact
1.6.1 How the Covid-19 is Affecting the Insulin Glargine Industry
1.6.1.1 Insulin Glargine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Insulin Glargine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Insulin Glargine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Insulin Glargine Market Size Estimates and Forecasts
2.1.1 Global Insulin Glargine Revenue 2015-2026
2.1.2 Global Insulin Glargine Sales 2015-2026
2.2 Insulin Glargine Market Size by Region: 2020 Versus 2026
2.2.1 Global Insulin Glargine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Insulin Glargine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Insulin Glargine Competitor Landscape by Players
3.1 Insulin Glargine Sales by Manufacturers
3.1.1 Insulin Glargine Sales by Manufacturers (2015-2020)
3.1.2 Insulin Glargine Sales Market Share by Manufacturers (2015-2020)
3.2 Insulin Glargine Revenue by Manufacturers
3.2.1 Insulin Glargine Revenue by Manufacturers (2015-2020)
3.2.2 Insulin Glargine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Insulin Glargine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Insulin Glargine Revenue in 2019
3.2.5 Global Insulin Glargine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Insulin Glargine Price by Manufacturers
3.4 Insulin Glargine Manufacturing Base Distribution, Product Types
3.4.1 Insulin Glargine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Insulin Glargine Product Type
3.4.3 Date of International Manufacturers Enter into Insulin Glargine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Insulin Glargine Market Size by Type (2015-2020)
4.1.1 Global Insulin Glargine Sales by Type (2015-2020)
4.1.2 Global Insulin Glargine Revenue by Type (2015-2020)
4.1.3 Insulin Glargine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Insulin Glargine Market Size Forecast by Type (2021-2026)
4.2.1 Global Insulin Glargine Sales Forecast by Type (2021-2026)
4.2.2 Global Insulin Glargine Revenue Forecast by Type (2021-2026)
4.2.3 Insulin Glargine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Insulin Glargine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Insulin Glargine Market Size by Application (2015-2020)
5.1.1 Global Insulin Glargine Sales by Application (2015-2020)
5.1.2 Global Insulin Glargine Revenue by Application (2015-2020)
5.1.3 Insulin Glargine Price by Application (2015-2020)
5.2 Insulin Glargine Market Size Forecast by Application (2021-2026)
5.2.1 Global Insulin Glargine Sales Forecast by Application (2021-2026)
5.2.2 Global Insulin Glargine Revenue Forecast by Application (2021-2026)
5.2.3 Global Insulin Glargine Price Forecast by Application (2021-2026)
6 North America
6.1 North America Insulin Glargine by Country
6.1.1 North America Insulin Glargine Sales by Country
6.1.2 North America Insulin Glargine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Insulin Glargine Market Facts & Figures by Type
6.3 North America Insulin Glargine Market Facts & Figures by Application
7 Europe
7.1 Europe Insulin Glargine by Country
7.1.1 Europe Insulin Glargine Sales by Country
7.1.2 Europe Insulin Glargine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Insulin Glargine Market Facts & Figures by Type
7.3 Europe Insulin Glargine Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Insulin Glargine by Region
8.1.1 Asia Pacific Insulin Glargine Sales by Region
8.1.2 Asia Pacific Insulin Glargine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Insulin Glargine Market Facts & Figures by Type
8.3 Asia Pacific Insulin Glargine Market Facts & Figures by Application
9 Latin America
9.1 Latin America Insulin Glargine by Country
9.1.1 Latin America Insulin Glargine Sales by Country
9.1.2 Latin America Insulin Glargine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Insulin Glargine Market Facts & Figures by Type
9.3 Central & South America Insulin Glargine Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Insulin Glargine by Country
10.1.1 Middle East and Africa Insulin Glargine Sales by Country
10.1.2 Middle East and Africa Insulin Glargine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Insulin Glargine Market Facts & Figures by Type
10.3 Middle East and Africa Insulin Glargine Market Facts & Figures by Application
11 Company Profiles
11.1 Sanofi-Aventis
11.1.1 Sanofi-Aventis Corporation Information
11.1.2 Sanofi-Aventis Description, Business Overview and Total Revenue
11.1.3 Sanofi-Aventis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi-Aventis Insulin Glargine Products Offered
11.1.5 Sanofi-Aventis Recent Development
11.2 Ganlee
11.2.1 Ganlee Corporation Information
11.2.2 Ganlee Description, Business Overview and Total Revenue
11.2.3 Ganlee Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Ganlee Insulin Glargine Products Offered
11.2.5 Ganlee Recent Development
11.3 Biocon
11.3.1 Biocon Corporation Information
11.3.2 Biocon Description, Business Overview and Total Revenue
11.3.3 Biocon Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Biocon Insulin Glargine Products Offered
11.3.5 Biocon Recent Development
11.1 Sanofi-Aventis
11.1.1 Sanofi-Aventis Corporation Information
11.1.2 Sanofi-Aventis Description, Business Overview and Total Revenue
11.1.3 Sanofi-Aventis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi-Aventis Insulin Glargine Products Offered
11.1.5 Sanofi-Aventis Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Insulin Glargine Market Estimates and Projections by Region
12.1.1 Global Insulin Glargine Sales Forecast by Regions 2021-2026
12.1.2 Global Insulin Glargine Revenue Forecast by Regions 2021-2026
12.2 North America Insulin Glargine Market Size Forecast (2021-2026)
12.2.1 North America: Insulin Glargine Sales Forecast (2021-2026)
12.2.2 North America: Insulin Glargine Revenue Forecast (2021-2026)
12.2.3 North America: Insulin Glargine Market Size Forecast by Country (2021-2026)
12.3 Europe Insulin Glargine Market Size Forecast (2021-2026)
12.3.1 Europe: Insulin Glargine Sales Forecast (2021-2026)
12.3.2 Europe: Insulin Glargine Revenue Forecast (2021-2026)
12.3.3 Europe: Insulin Glargine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Insulin Glargine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Insulin Glargine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Insulin Glargine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Insulin Glargine Market Size Forecast by Region (2021-2026)
12.5 Latin America Insulin Glargine Market Size Forecast (2021-2026)
12.5.1 Latin America: Insulin Glargine Sales Forecast (2021-2026)
12.5.2 Latin America: Insulin Glargine Revenue Forecast (2021-2026)
12.5.3 Latin America: Insulin Glargine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Insulin Glargine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Insulin Glargine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Insulin Glargine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Insulin Glargine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Insulin Glargine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Insulin Glargine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables
Table 1. Insulin Glargine Market Segments
Table 2. Ranking of Global Top Insulin Glargine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Insulin Glargine Market Size Growth Rate by Type 2020-2026 (M mL) & (US$ Million)
Table 4. Major Manufacturers of Single Dose Vial
Table 5. Major Manufacturers of Pre-filled Syringe
Table 6. COVID-19 Impact Global Market: (Four Insulin Glargine Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Insulin Glargine Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Insulin Glargine Players to Combat Covid-19 Impact
Table 11. Global Insulin Glargine Market Size Growth Rate by Application 2020-2026 (M mL)
Table 12. Global Insulin Glargine Market Size by Region (M mL) & (US$ Million): 2020 VS 2026
Table 13. Global Insulin Glargine Sales by Regions 2015-2020 (M mL)
Table 14. Global Insulin Glargine Sales Market Share by Regions (2015-2020)
Table 15. Global Insulin Glargine Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Insulin Glargine Sales by Manufacturers (2015-2020) (M mL)
Table 17. Global Insulin Glargine Sales Share by Manufacturers (2015-2020)
Table 18. Global Insulin Glargine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Insulin Glargine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insulin Glargine as of 2019)
Table 20. Insulin Glargine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Insulin Glargine Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Insulin Glargine Price (2015-2020) (USD/mL)
Table 23. Insulin Glargine Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Insulin Glargine Product Type
Table 25. Date of International Manufacturers Enter into Insulin Glargine Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Insulin Glargine Sales by Type (2015-2020) (M mL)
Table 28. Global Insulin Glargine Sales Share by Type (2015-2020)
Table 29. Global Insulin Glargine Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Insulin Glargine Revenue Share by Type (2015-2020)
Table 31. Insulin Glargine Average Selling Price (ASP) by Type 2015-2020 (USD/mL)
Table 32. Global Insulin Glargine Sales by Application (2015-2020) (M mL)
Table 33. Global Insulin Glargine Sales Share by Application (2015-2020)
Table 34. North America Insulin Glargine Sales by Country (2015-2020) (M mL)
Table 35. North America Insulin Glargine Sales Market Share by Country (2015-2020)
Table 36. North America Insulin Glargine Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Insulin Glargine Revenue Market Share by Country (2015-2020)
Table 38. North America Insulin Glargine Sales by Type (2015-2020) (M mL)
Table 39. North America Insulin Glargine Sales Market Share by Type (2015-2020)
Table 40. North America Insulin Glargine Sales by Application (2015-2020) (M mL)
Table 41. North America Insulin Glargine Sales Market Share by Application (2015-2020)
Table 42. Europe Insulin Glargine Sales by Country (2015-2020) (M mL)
Table 43. Europe Insulin Glargine Sales Market Share by Country (2015-2020)
Table 44. Europe Insulin Glargine Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Insulin Glargine Revenue Market Share by Country (2015-2020)
Table 46. Europe Insulin Glargine Sales by Type (2015-2020) (M mL)
Table 47. Europe Insulin Glargine Sales Market Share by Type (2015-2020)
Table 48. Europe Insulin Glargine Sales by Application (2015-2020) (M mL)
Table 49. Europe Insulin Glargine Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Insulin Glargine Sales by Region (2015-2020) (M mL)
Table 51. Asia Pacific Insulin Glargine Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Insulin Glargine Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Insulin Glargine Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Insulin Glargine Sales by Type (2015-2020) (M mL)
Table 55. Asia Pacific Insulin Glargine Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Insulin Glargine Sales by Application (2015-2020) (M mL)
Table 57. Asia Pacific Insulin Glargine Sales Market Share by Application (2015-2020)
Table 58. Latin America Insulin Glargine Sales by Country (2015-2020) (M mL)
Table 59. Latin America Insulin Glargine Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Insulin Glargine Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Insulin Glargine Revenue Market Share by Country (2015-2020)
Table 62. Latin America Insulin Glargine Sales by Type (2015-2020) (M mL)
Table 63. Latin America Insulin Glargine Sales Market Share by Type (2015-2020)
Table 64. Latin America Insulin Glargine Sales by Application (2015-2020) (M mL)
Table 65. Latin America Insulin Glargine Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Insulin Glargine Sales by Country (2015-2020) (M mL)
Table 67. Middle East and Africa Insulin Glargine Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Insulin Glargine Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Insulin Glargine Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Insulin Glargine Sales by Type (2015-2020) (M mL)
Table 71. Middle East and Africa Insulin Glargine Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Insulin Glargine Sales by Application (2015-2020) (M mL)
Table 73. Middle East and Africa Insulin Glargine Sales Market Share by Application (2015-2020)
Table 74. Sanofi-Aventis Corporation Information
Table 75. Sanofi-Aventis Description and Major Businesses
Table 76. Sanofi-Aventis Insulin Glargine Production (M mL), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2015-2020)
Table 77. Sanofi-Aventis Product
Table 78. Sanofi-Aventis Recent Development
Table 79. Ganlee Corporation Information
Table 80. Ganlee Description and Major Businesses
Table 81. Ganlee Insulin Glargine Production (M mL), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2015-2020)
Table 82. Ganlee Product
Table 83. Ganlee Recent Development
Table 84. Biocon Corporation Information
Table 85. Biocon Description and Major Businesses
Table 86. Biocon Insulin Glargine Production (M mL), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2015-2020)
Table 87. Biocon Product
Table 88. Biocon Recent Development
Table 89. Global Insulin Glargine Sales Forecast by Regions (2021-2026) (M mL)
Table 90. Global Insulin Glargine Sales Market Share Forecast by Regions (2021-2026)
Table 91. Global Insulin Glargine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 92. Global Insulin Glargine Revenue Market Share Forecast by Regions (2021-2026)
Table 93. North America: Insulin Glargine Sales Forecast by Country (2021-2026) (M mL)
Table 94. North America: Insulin Glargine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 95. Europe: Insulin Glargine Sales Forecast by Country (2021-2026) (M mL)
Table 96. Europe: Insulin Glargine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 97. Asia Pacific: Insulin Glargine Sales Forecast by Region (2021-2026) (M mL)
Table 98. Asia Pacific: Insulin Glargine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 99. Latin America: Insulin Glargine Sales Forecast by Country (2021-2026) (M mL)
Table 100. Latin America: Insulin Glargine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 101. Middle East and Africa: Insulin Glargine Sales Forecast by Country (2021-2026) (M mL)
Table 102. Middle East and Africa: Insulin Glargine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 104. Key Challenges
Table 105. Market Risks
Table 106. Main Points Interviewed from Key Insulin Glargine Players
Table 107. Insulin Glargine Customers List
Table 108. Insulin Glargine Distributors List
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Insulin Glargine Product Picture
Figure 2. Global Insulin Glargine Sales Market Share by Type in 2020 & 2026
Figure 3. Single Dose Vial Product Picture
Figure 4. Pre-filled Syringe Product Picture
Figure 5. Global Insulin Glargine Sales Market Share by Application in 2020 & 2026
Figure 6. Treat type2 diabetes
Figure 7. Treat type1 diabetes
Figure 8. Insulin Glargine Report Years Considered
Figure 9. Global Insulin Glargine Market Size 2015-2026 (US$ Million)
Figure 10. Global Insulin Glargine Sales 2015-2026 (M mL)
Figure 11. Global Insulin Glargine Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Insulin Glargine Sales Market Share by Region (2015-2020)
Figure 13. Global Insulin Glargine Sales Market Share by Region in 2019
Figure 14. Global Insulin Glargine Revenue Market Share by Region (2015-2020)
Figure 15. Global Insulin Glargine Revenue Market Share by Region in 2019
Figure 16. Global Insulin Glargine Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Insulin Glargine Revenue in 2019
Figure 18. Insulin Glargine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Insulin Glargine Sales Market Share by Type (2015-2020)
Figure 20. Global Insulin Glargine Sales Market Share by Type in 2019
Figure 21. Global Insulin Glargine Revenue Market Share by Type (2015-2020)
Figure 22. Global Insulin Glargine Revenue Market Share by Type in 2019
Figure 23. Global Insulin Glargine Market Share by Price Range (2015-2020)
Figure 24. Global Insulin Glargine Sales Market Share by Application (2015-2020)
Figure 25. Global Insulin Glargine Sales Market Share by Application in 2019
Figure 26. Global Insulin Glargine Revenue Market Share by Application (2015-2020)
Figure 27. Global Insulin Glargine Revenue Market Share by Application in 2019
Figure 28. North America Insulin Glargine Sales Growth Rate 2015-2020 (M mL)
Figure 29. North America Insulin Glargine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Insulin Glargine Sales Market Share by Country in 2019
Figure 31. North America Insulin Glargine Revenue Market Share by Country in 2019
Figure 32. U.S. Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 33. U.S. Insulin Glargine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 35. Canada Insulin Glargine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Insulin Glargine Market Share by Type in 2019
Figure 37. North America Insulin Glargine Market Share by Application in 2019
Figure 38. Europe Insulin Glargine Sales Growth Rate 2015-2020 (M mL)
Figure 39. Europe Insulin Glargine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Insulin Glargine Sales Market Share by Country in 2019
Figure 41. Europe Insulin Glargine Revenue Market Share by Country in 2019
Figure 42. Germany Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 43. Germany Insulin Glargine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 45. France Insulin Glargine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 47. U.K. Insulin Glargine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 49. Italy Insulin Glargine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 51. Russia Insulin Glargine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Insulin Glargine Market Share by Type in 2019
Figure 53. Europe Insulin Glargine Market Share by Application in 2019
Figure 54. Asia Pacific Insulin Glargine Sales Growth Rate 2015-2020 (M mL)
Figure 55. Asia Pacific Insulin Glargine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Insulin Glargine Sales Market Share by Region in 2019
Figure 57. Asia Pacific Insulin Glargine Revenue Market Share by Region in 2019
Figure 58. China Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 59. China Insulin Glargine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 61. Japan Insulin Glargine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 63. South Korea Insulin Glargine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 65. India Insulin Glargine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 67. Australia Insulin Glargine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 69. Taiwan Insulin Glargine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 71. Indonesia Insulin Glargine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 73. Thailand Insulin Glargine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 75. Malaysia Insulin Glargine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 77. Philippines Insulin Glargine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 79. Vietnam Insulin Glargine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Insulin Glargine Market Share by Type in 2019
Figure 81. Asia Pacific Insulin Glargine Market Share by Application in 2019
Figure 82. Latin America Insulin Glargine Sales Growth Rate 2015-2020 (M mL)
Figure 83. Latin America Insulin Glargine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Insulin Glargine Sales Market Share by Country in 2019
Figure 85. Latin America Insulin Glargine Revenue Market Share by Country in 2019
Figure 86. Mexico Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 87. Mexico Insulin Glargine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 89. Brazil Insulin Glargine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 91. Argentina Insulin Glargine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Insulin Glargine Market Share by Type in 2019
Figure 93. Latin America Insulin Glargine Market Share by Application in 2019
Figure 94. Middle East and Africa Insulin Glargine Sales Growth Rate 2015-2020 (M mL)
Figure 95. Middle East and Africa Insulin Glargine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Insulin Glargine Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Insulin Glargine Revenue Market Share by Country in 2019
Figure 98. Turkey Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 99. Turkey Insulin Glargine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 101. Saudi Arabia Insulin Glargine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. UAE Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 103. UAE Insulin Glargine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Insulin Glargine Market Share by Type in 2019
Figure 105. Middle East and Africa Insulin Glargine Market Share by Application in 2019
Figure 106. Sanofi-Aventis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 107. Ganlee Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Biocon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. North America Insulin Glargine Sales Growth Rate Forecast (2021-2026) (M mL)
Figure 110. North America Insulin Glargine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Insulin Glargine Sales Growth Rate Forecast (2021-2026) (M mL)
Figure 112. Europe Insulin Glargine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Insulin Glargine Sales Growth Rate Forecast (2021-2026) (M mL)
Figure 114. Asia Pacific Insulin Glargine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Insulin Glargine Sales Growth Rate Forecast (2021-2026) (M mL)
Figure 116. Latin America Insulin Glargine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Insulin Glargine Sales Growth Rate Forecast (2021-2026) (M mL)
Figure 118. Middle East and Africa Insulin Glargine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
  • Global Metformin Hydrochloride Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104
    Metformin hydrochloride is The raw material of finished product metformin hydrochloride drugs. That is The API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in The management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Metformin hydrochloride is a white to off-white crystall......
  • Global Antidiabetic Sulphonylureas Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Antidiabetic Sulphonylureas market: According to our latest research, the global Antidiabetic Sulphonylureas market looks promising in the next 5 years. As of 2022, the global Antidiabetic Sulphonylureas market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of t......
  • Global Insulin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101
    According to our LPI (LP Information) latest study, the global Insulin market size was valued at US$ million in 2023. With growing demand in downstream market, the Insulin is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Insulin market. Insulin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization......
  • Global Insulin API Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116
    According to our LPI (LP Information) latest study, the global Insulin API market size was valued at US$ 1707.6 million in 2023. With growing demand in downstream market, the Insulin API is forecast to a readjusted size of US$ 2101.4 million by 2030 with a CAGR of 3.0% during review period. The research report highlights the growth potential of the global Insulin API market. Insulin API are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • Global Glucagon Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101
    According to our LPI (LP Information) latest study, the global Glucagon market size was valued at US$ 543.9 million in 2023. With growing demand in downstream market, the Glucagon is forecast to a readjusted size of US$ 835.7 million by 2030 with a CAGR of 6.3% during review period. The research report highlights the growth potential of the global Glucagon market. Glucagon are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
  • Global Acarbose Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Acarbose market size was valued at US$ 135.8 million in 2023. With growing demand in downstream market, the Acarbose is forecast to a readjusted size of US$ 165.9 million by 2030 with a CAGR of 2.9% during review period. The research report highlights the growth potential of the global Acarbose market. Acarbose are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
  • Global Insulin Glargine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 77
    According to our LPI (LP Information) latest study, the global Insulin Glargine market size was valued at US$ 6562.1 million in 2023. With growing demand in downstream market, the Insulin Glargine is forecast to a readjusted size of US$ 8722.5 million by 2030 with a CAGR of 4.1% during review period. The research report highlights the growth potential of the global Insulin Glargine market. Insulin Glargine are expected to show stable growth in the future market. However, product differen......
  • Global Liraglutide Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 103
    According to our LPI (LP Information) latest study, the global Liraglutide market size was valued at US$ million in 2023. With growing demand in downstream market, the Liraglutide is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Liraglutide market. Liraglutide are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ch......
  • Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global Glucagon Like Peptide-1 (GLP-1) Agonists market size was valued at US$ 8624.4 million in 2023. With growing demand in downstream market, the Glucagon Like Peptide-1 (GLP-1) Agonists is forecast to a readjusted size of US$ 21310 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Glucagon Like Peptide-1 (GLP-1) Agonists market. Glucagon Like Peptide-1 (GL......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs